Dallmann, R;Weyermann, P;Anklin, C;Boroff, M;Bray-French, K;Cardel, B;Courdier-Fruh, I;Deppe, H;Dubach-Powell, J;Erb, M;Haefeli, RH;Henneböhle, M;Herzner, H;Hufschmid, M;Marks, DL;Nordhoff, S;Papp, M;Rummey, C;Santos, G;Schärer, F;Siendt, H;Soeberdt, M;Sumanovski, LT;Terinek, M;Mondadori, C;Güven, N;Feurer, A.The orally active melanocortin-4 receptor antagonist BL-6020/979: a promising candidate for the treatment of cancer cachexia..J Cachexia Sarcopenia Muscle.2011.2.3.163-174